Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb
University of Pennsylvania
Bristol-Myers Squibb
Incyte Corporation
Bristol-Myers Squibb
UNC Lineberger Comprehensive Cancer Center
Intensity Therapeutics, Inc.
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
M.D. Anderson Cancer Center
Bristol-Myers Squibb
University of Michigan Rogel Cancer Center
Incyte Corporation
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bristol-Myers Squibb